| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/14/2013 | US20130040837 Aptamer cell compositions |
| 02/14/2013 | US20130040834 Sample plate systems and methods |
| 02/14/2013 | US20130040832 Identifying viral cell tropism |
| 02/14/2013 | US20130040829 In vitro model of latent mycobacterial infection |
| 02/14/2013 | US20130040824 Detection of genetic or molecular aberrations associated with cancer |
| 02/14/2013 | US20130040815 Uses and detection of herbicide resistance genes for resistance to aryloxyalkanoate herbicides |
| 02/14/2013 | US20130040367 Phosphotriesterase from agrobacterium radiobacter p230 |
| 02/14/2013 | US20130040338 Device for capturing object and method for using the same |
| 02/14/2013 | US20130040336 Mutant strains of escherichia coli, a method of testing potential antibacterial agents using said strains as well as a testing kit |
| 02/14/2013 | US20130040334 Biochip assembly and assay method thereof |
| 02/14/2013 | US20130040332 Method for assaying cell movement |
| 02/14/2013 | US20130040331 LABEL-FREE METHODS RELATED TO hERG POTASSIUM ION CHANNELS |
| 02/14/2013 | US20130040330 Method for differentiation induction in cultured stem cells |
| 02/14/2013 | US20130040328 Assay for phytol-free chlorophyll derivatives |
| 02/14/2013 | US20130040327 Methods for Identifying Allosteric and Other Novel Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibitors |
| 02/14/2013 | US20130040324 Perifusion device |
| 02/14/2013 | US20130040315 Human and murine stem-cell lines: models of endothelial cell precursors |
| 02/14/2013 | US20130040310 Ulk1 compositions, inhibitors, screening and methods of use |
| 02/14/2013 | US20130040304 Compositions and Methods for Engineering Cells |
| 02/14/2013 | US20130040303 Biomarker for Alzheimer's Disease and/or Mild Cognitive Impairment, and Use Thereof |
| 02/14/2013 | US20130040302 Methods for cell reprogramming and genome engineering |
| 02/14/2013 | US20130040301 Methods of Evaluating Transplant Rejection |
| 02/14/2013 | US20130040300 Methods for Beaming |
| 02/14/2013 | US20130040299 Method for detecting or monitoring sepsis by analysing cytokine mrna expression levels |
| 02/14/2013 | US20130040298 Two-pore channels as regulators of proliferation in cancer |
| 02/14/2013 | US20130040297 Process for the production of cells which are capable of converting arabinose |
| 02/14/2013 | US20130040296 Method and rapid test device for detection of target molecule |
| 02/14/2013 | US20130040294 Compositions and methods for performing hybridizations with no denaturation |
| 02/14/2013 | US20130040293 Methods for genetic analysis of dna to detect sequence variances |
| 02/14/2013 | US20130040292 Nanoparticle biosensor, method of preparing same and uses thereof |
| 02/14/2013 | US20130040291 Detection and Quantification of Cellular Stress Response Resolution Pathway Expression and Functionality and the Effects of Agents or Conditions Thereupon |
| 02/14/2013 | US20130040290 Methods and systems for ultra-trace analysis of liquids |
| 02/14/2013 | US20130040289 Breast milk ethanol screening system and method |
| 02/14/2013 | US20130040288 Biological Specimen Collection and Transport System and Method of Use |
| 02/14/2013 | US20130040287 Methods for Detection and Typing of Nucleic Acids |
| 02/14/2013 | US20130040286 Rapid Diagnostic Device, Assay and Multifunctional Buffer |
| 02/14/2013 | US20130040285 Saliva Polymerase Chain Reaction Assay for Cytomegalovirus Infection |
| 02/14/2013 | US20130040284 Hbv drug resistance methods |
| 02/14/2013 | US20130039946 Vaccine comprising an attenuated pestivirus |
| 02/14/2013 | US20130039930 Biomarker for sensitivity to therapy with a notch inhibitor |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039917 Diagnostic and therapeutic target |
| 02/14/2013 | US20130039909 Predicting response to a her inhibitor |
| 02/14/2013 | US20130039908 Prognostic markers and methods for prostate cancer |
| 02/14/2013 | US20130039887 Methods of Identifying and Using Anti-Viral Compounds |
| 02/14/2013 | US20130039856 Products and Methods |
| 02/14/2013 | US20130039854 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer |
| 02/14/2013 | US20130038868 Identification of objects using plasmon resonant particles |
| 02/14/2013 | US20130037421 Systems and methods for determining a substantially hematocrit independent analyte concentration |
| 02/14/2013 | US20130037040 Compositions and methods for minimizing nornicotine synthesis in tobacco |
| 02/14/2013 | DE102011052604A1 Apparatus useful for improving the quality of drinking water and/or service water, arranged in line or line section, comprises tubular housing, whose inner side is arranged with support body, through which an active carbon filter is drawn |
| 02/14/2013 | CA2849072A1 Compositions and methods relating to nucleic acid nano-and micro-technology |
| 02/14/2013 | CA2846211A1 Microrna biomarkers |
| 02/14/2013 | CA2844671A1 Biomarker compositions and methods |
| 02/14/2013 | CA2844103A1 Cardiovascular disease |
| 02/14/2013 | CA2843949A1 Fibrosis susceptibility il22ra2 gene and uses thereof |
| 02/14/2013 | CA2843556A1 Method for dissolution testing of solid compositions containing digestive enzymes |
| 02/14/2013 | CA2842821A1 Isolation and detection of cancer cells |
| 02/14/2013 | CA2841874A1 Methods and compositions for modulating voltage-gated calcium channel function |
| 02/14/2013 | CA2838562A1 Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| 02/13/2013 | EP2557520A2 Determining a nucleic acid sequence imbalance |
| 02/13/2013 | EP2557519A2 Determining a nucleic acid sequence imbalance |
| 02/13/2013 | EP2557518A2 Determining a nucleic acid sequence imbalance |
| 02/13/2013 | EP2557517A2 Determining a nucleic acid sequence imbalance |
| 02/13/2013 | EP2557180A1 Methods and compositions for dectecting autoimmune disorders |
| 02/13/2013 | EP2557179A1 Test method for determining susceptibility to or state of immune system disorder or joint disorder |
| 02/13/2013 | EP2557178A1 Method for detecting pneumonia causative bacteria using nucleic acid chromatography |
| 02/13/2013 | EP2557162A1 Method of detecting rhabdomyosarcoma using sample derived from body fluid |
| 02/13/2013 | EP2557159A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma |
| 02/13/2013 | EP2557158A1 Biopolymer analysis method, biopolymer analyzer, and biopolymer analysis chip |
| 02/13/2013 | EP2557156A1 Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same |
| 02/13/2013 | EP2557152A1 Key genes, micrornas, other non-coding rnas and combinations thereof for identifying and regulating pluripotency of cells |
| 02/13/2013 | EP2556371A2 High throughput screening of ion channels |
| 02/13/2013 | EP2556185A2 Gene-expression profiling with reduced numbers of transcript measurements |
| 02/13/2013 | EP2556173A2 Improved thermal uniformity for thermal cycler instrumentation using dynamic control |
| 02/13/2013 | EP2556172A1 Circulating biomarkers for disease |
| 02/13/2013 | EP2556171A1 Spatially encoded biological assays |
| 02/13/2013 | EP2556169A2 Methods for categorising cancer such as breast cancer |
| 02/13/2013 | EP2556168A1 Method for detecting specific nucleic acid sequences |
| 02/13/2013 | EP2556167A1 Rad51c as a human cancer susceptibility gene |
| 02/13/2013 | EP2556166A1 Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family |
| 02/13/2013 | EP2556165A1 Assay for phytol-free chlorophyll derivatives |
| 02/13/2013 | EP2556164A1 Method for detecting clusters of biological particles |
| 02/13/2013 | EP2556163A1 High mannose glycans |
| 02/13/2013 | EP2556157A1 Method for precipitating anionic surfactant ions in the presence of nucleic acids |
| 02/13/2013 | EP2556154A1 Compositions and methods for the rapid detection of legionella pneumophila |
| 02/13/2013 | EP2556146A2 Methods and systems for reducing dna fragmentation in a processed sperm sample |
| 02/13/2013 | EP2556089A1 Self-assembling half-antibodies |
| 02/13/2013 | EP2556047A1 Method of analysing a cell or other biological material containing a nucleic acid |
| 02/13/2013 | EP2555793A1 Methods for modeling protein stability |
| 02/13/2013 | EP2555790A1 THERAPEUTIC USE OF THE ß2m PROTEIN |
| 02/13/2013 | CN202730128U Warfarin personalized medication gene sequencing kit |
| 02/13/2013 | CN102933965A Molecular classification of multiple myeloma |
| 02/13/2013 | CN102933723A Methods and kits for diagnosing conditions related to hypoxia |
| 02/13/2013 | CN102933722A Methods of detecting residual amounts of polymers used in the purification of biomolecules |
| 02/13/2013 | CN102933721A Combinatorial sequence barcodes for high throughput screening |
| 02/13/2013 | CN102933720A Method for generating a double stranded nucleic acid with a single stranded overhang |
| 02/13/2013 | CN102933719A Compositions and methods for microrna expession profiling in plasma of colorectal cancer |
| 02/13/2013 | CN102933300A Reaction vessel for pcr device and method of performing pcr |
| 02/13/2013 | CN102933072A Barley and uses thereof |